Table 2 Baseline characteristics of 24 patients included in the study.
Data, mean (SD) | r-hGH (n = 12) | Control (n = 12) | p value t student test |
|---|---|---|---|
Demographics | |||
Age, years | 47,4 (7,6) | 49,6 (9,4) | 0.555 |
Weight, kg | 72,9 (12,3) | 66,0 (9,4) | 0.153 |
Waist, cm | 89.2 (10.3) | 76.6 (3.2) | 0.01 |
BMI, Kg/m2 | 25,1 (5,3) | 162,2 (5,9) | 0.334 |
Fibromyalgia symptoms duration (prior study), months | 21 (6) | 23 (7) | 0,204 |
Vital signs | |||
Systolic blood pressure, mm Hg | 124,8 (15,4) | 117,5 (10,3) | 0.222 |
Diastolic blood pressure, mm Hg | 80,8 (6,6) | 74,2 (7,9) | 0.052 |
Heart rate, beats/min | 75,8 (6,4) | 77,9 (11,8) | 0.721 |
Laboratory data | |||
GH, ng/mL | 0,4 (0,3) | 0,9 (0,8) | 0.134 |
IGF-1 g/L | 173.3 (49.4) | 98.6 (36.0) | <0.001 |
TSH, μU/mL | 1.3 (0.9) | 1.3 (0.9) | 0.998 |
free T4, ng/mL | 3.3 (4.9) | 5.5 (6.9) | 0.433 |
free T3, pg/mL | 3.7 (0.7) | 2.9 (0.5) | 0.041 |
Estradiol E2, pg/mL | 117.8 (17.7) | 98.4 (81.7) | 0.708 |
P4, ng/mL | 0.4 (0.3) | 0.7 (0.3) | 0.287 |
Urinary free cortisol, μg/24 h | 98.2 (66.1) | 44.5 (11.9) | 0.030 |
Insulinemia U/dL | 11.9 (14.7) | 6.0 (2.7) | 0.306 |
Apolipoprotein B, mg/L | 102.8 (26.7) | 98.7 (66.1) | 0.744 |
C-Reactive protein, mg/L | 3.2 (0.4) | 3.5 (0.0) | 0.417 |
Erythrocyte sedimentation rate, mm | 12.8 (5.8) | 11.0 (4.6) | 0.482 |